OCGNSMALL

Ocugen, Inc.

HealthcareBiotechnology
$1.46
$0.00(-2.35%)
52W$0.64
$2.73
Updated May 7, 12:00 AM
RSI36
RS Rating79/99
Beta1.63
Volatility81%
F-Score2/9
Mkt Cap$493M
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

Ocugen, Inc. shows underlying uptrend characteristics but has temporarily lost support at the 50-day moving average. Relative strength is moderate (RS Rating: 79), indicating performance broadly in line with the market. Earnings contraction of 19% provides fundamental context to the price action. Investors should exercise caution due to high volatility (81% annualized), which requires wider risk management.

Relative Strength
79
out of 99
Average
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
1.63
vs S&P 500
HIGH BETA
52W Position
39%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$1.88
50 SMA > 100 SMA$1.69
100 SMA > 150 SMA$1.60
150 SMA > 200 SMA$1.49

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$1.75-17.06%BELOW
50 SMA$1.88-22.57%BELOW
100 SMA$1.69-14.01%BELOW
150 SMA$1.60-9.30%BELOW
200 SMA$1.49-2.04%BELOW

Price Performance

1D-2.3%
1W-13.4%
1M-17.8%
3M+9.4%
6M+5.4%
YTD+5.4%
1Y+103.4%
3Y+26.5%
52-Week Trading Range39% from low
$1.46
52W Low$0.64
52W High$2.73

Technical Indicators

RSI (14)BEARISH
36.5
305070
VCP ScoreCOOL
3/10
Base depth: 93.8%

Risk Profile

Beta
1.63
52W Vol
81%
ATR
$0.12
Max DD (1Y)
-39%

Volume Analysis

Today
15.10M
50D Avg
9.31M
Vol Ratio
1.62x
Liquidity
MODERATE

Earnings Momentum

Q1'25-13%
$-0.05
Q2'25-26%
$-0.05
Q3'25-42%
$-0.07
Q4'25-19%
$-0.06
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:+152.50%
3 Years:+21.05%
TTM:+8.83%

Compounded Profit Growth

10 Years:+47.52%
5 Years:
3 Years:
TTM:-24.96%

Stock Price CAGR

10 Years:-34.45%
5 Years:-31.40%
3 Years:+26.55%
1 Year:+103.44%

Return on Equity

10Y Avg:-459.5%
5Y Avg:-248.5%
3Y Avg:-347.0%
Last Year:-2626.4%

Key Metrics

Market Cap$493M
Gross Margin45.9%
Net Margin-15.4%
Piotroski F-Score2/9

Frequently Asked Questions

Is OCGN in an uptrend right now?

OCGN has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is OCGN overbought or oversold?

OCGN's RSI (14) is 36. The stock is in neutral territory, neither overbought nor oversold.

Is OCGN outperforming the market?

OCGN has a Relative Strength (RS) Rating of 79 out of 99. OCGN is performing about average compared to the market.

Where is OCGN in its 52-week range?

OCGN is trading at $1.46, which is 53% of its 52-week high ($2.73) and 39% above its 52-week low ($0.64).

How volatile is OCGN?

OCGN has a Beta of 1.63 and 52-week volatility of 81%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.